USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Yantai Ausbio Laboratories Co., Ltd.

USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

9
Total patents granted
7
CPC technology areas
18.0
Avg claims per patent
+100%
5-year filing velocity

The verdict

Yantai holds 9 US patents across 7 technology areas, rank #30,620 of 50,000 tracked assignees.

#30,620
of 50,000 US assignees by volume
Top 51%
by Innovation Score (34.8/100)
18.0
avg claims per patent
+100%
filing velocity, last 5 yrs

Portfolio overview

Yantai Ausbio Laboratories Co., Ltd. has been granted 9 US utility patents between 2018 and 2024, placing Yantai Ausbio Laboratories Co., Ltd. at rank #30,620 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Yantai Ausbio Laboratories Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Yantai sits between Xybix Systems, Inc. (9 patents, rank #30,616) and YSN Imports, Llc (9 patents, rank #30,624) - the closest US assignees by grant volume. The composite Innovation Score of 34.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 3 in the 2015–2019 window, a +100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Yantai Ausbio Laboratories Co., Ltd.'s 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Yantai Ausbio Laboratories Co., Ltd. against peers pursuing similar technology classes.

Who files at Yantai's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Yantai holds 9 patents at rank #30,620, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Yantai

By rank, the assignees closest to #30,620 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Yantai's primary technology class.

Yantai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

35 Top 51% higher than 49% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20182019202120222024 3
USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Yantai Ausbio Laboratories Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 11.1%
2019 2 22.2%
2021 2 22.2%
2022 1 11.1%
2024 3 33.3%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#30,620

Across all tracked assignees

Innovation Score

34.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Yantai Ausbio Laboratories Co., Ltd. hold?
Yantai Ausbio Laboratories Co., Ltd. holds 9 US granted patents filed between 2018 and 2024, spanning 7 technology areas.
What is Yantai Ausbio Laboratories Co., Ltd.'s Innovation Score?
Yantai Ausbio Laboratories Co., Ltd. has an Innovation Score of 34.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Yantai Ausbio Laboratories Co., Ltd. focus on?
Yantai Ausbio Laboratories Co., Ltd.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 9 patents. The company has filed patents in 7 CPC subclasses total.
Is Yantai Ausbio Laboratories Co., Ltd.'s patent filing rate increasing or decreasing?
Yantai Ausbio Laboratories Co., Ltd.'s recent filing velocity is +100% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Yantai Ausbio Laboratories Co., Ltd.'s patents?
Yantai Ausbio Laboratories Co., Ltd.'s patents average 18.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Yantai Ausbio Laboratories Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Yantai's 9 grants land it in the top 51% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Yantai ranks #30,620 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.